Mitral Tissue Inhibitor of Metalloproteinase 2 Is Associated with Mitral Valve Surgery Outcome

• Tsung-Hsien Lin,

  Affiliations Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, Faculty of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

  ⨯
• Sheau-Fang Yang,

  Affiliations Department of Pathology, Kaohsiung Medical University, Kaohsiung, Taiwan, Kaohsiung Medical University Hospital, Department of Pathology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, Faculty of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

  ⨯
• Chaw-Chi Chiu,

  Affiliations Division of Cardiovascular Surgery, Department of Surgery, Kaohsiung Medical University, Kaohsiung, Taiwan, Faculty of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

  ⨯
• Ho-Ming Su,

  Affiliation Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

  ⨯
• Wen-Chol Voon,

  Affiliations Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, Faculty of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

  ⨯
• Chee-Yin Chai,

  Affiliations Department of Pathology, Kaohsiung Medical University, Kaohsiung, Taiwan, Faculty of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

  ⨯
• Wen-Ter Lai,

  Affiliations Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, Faculty of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

  ⨯
• Sheng-Hsiung Sheu

  * E-mail: sheush@kmu.edu.tw

  Affiliations Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, Faculty of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

  ⨯